Novel “Tissue-in-a-CUBE” model mimics blood-brain barrier for drug testing

The Eu­ro­pean Com­mis­sion made the rare de­ci­sion Mon­day not to adopt the neg­a­tive opin­ion of the Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man

The EU re­view of Ei­sai’s Alzheimer’s drug lecanemab was de­layed this week be­cause of a pro­ce­dur­al is­sue at the Eu­ro­pean Med­i­cines Agency. On Fri­day, Ei­sai